On the other hand, B cell activity in patients affected by breast cancer undergoing chemotherapy is typically enhanced and can lead to diverse effects, eliciting either anti-tumor T cell immunity or, conversely, the switch of CD4+ T cells to T-regulatory cells with immunosuppressive effects [24, 25]. Here, CD4 is linked to neoplasm.